mezavant 1200 mg
takeda pharmaceuticals international ag ireland branch - mesalazin - enterodepottablett - 1200 mg
kesimpta
novartis ireland ltd - ofatumumab - multippel sklerose, relapsing-remitting - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
lifmior
pfizer europe ma eeig - etanercept - arthritis, psoriatic; spondylitis, ankylosing; psoriasis - immunsuppressive - revmatoid artritt;juvenil idiopatisk arthritispsoriatic leddgikt;aksial spondyloarthritis;plaque psoriasis;paediatric plakkpsoriasis.
chromium [51cr] edta injection ge healthcare 3.7 mbq/ ml
ge healthcare ltd - krom (51cr) edetat - injeksjonsvæske, oppløsning - 3.7 mbq/ ml
toujeo 300 e/ ml
orifarm as - insulin glargin - injeksjonsvæske, oppløsning i ferdigfylt penn - 300 e/ ml
toujeo (previously optisulin)
sanofi-aventis deutschland gmbh - insulin glargin - sukkersyke - legemidler som brukes i diabetes - behandling av diabetes mellitus hos voksne, ungdom og barn fra 6 år.
mezavant 1200 mg
2care4 aps - mesalazin - enterodepottablett - 1200 mg
mezavant 1200 mg
2care4 aps - mesalazin - enterodepottablett - 1200 mg
mezavant 1200 mg
orifarm as - mesalazin - enterodepottablett - 1200 mg
mezavant 1200 mg
orifarm as - mesalazin - enterodepottablett - 1200 mg